Clinical Trial Update: Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating how obesity affects cyclosporine trough levels in patients with nephrotic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Alexandria University | Conditions: Nephrotic Syndrome | Phase 4 | Status: UNKNOWN